The Joint Corp (JYNT) - Company Total Revenue

thejoint.com - graphic logo of issuer JYNT

The Joint Corp. (JYNT) employs an asset-light strategy, collecting royalties via an IT platform without Capex expenditures. The company's sales volatility reflects the market consensus, while the 0.06 metric indicates the status of current revenue. Franchising enables the rapid expansion of the network across the country. However, labor shortages and rising wages are pressuring expenses, although stable cash flow mitigates debt risks.

The Joint Corp (JYNT) - Company Revenue from 07/04/2022 to 11/14/2026

Comprehensive metric breakdowns and analytics for The Joint Chiropractic (JYNT)

Comprehensive company analysis:The Joint JYNT
Original product of The Joint Corporation

Investors seek a balance between asset cost and real efficiency. This indicator tracks daily sales volume, allowing short-term noise to be filtered out from the sustainable fundamental trend. For The Joint Corp. (JYNT), this metric reflects the expansion rate of the franchise network and customer engagement with the subscription service. Stable patient traffic directly determines the viability of the business model. By analyzing the company's gross sales levels, one can assess the issuer's ability to scale revenue.

Competing companies

HCA: Company Sales Revenue|Revenue and Sales Volume THC|FMS - Company Total Revenue|Solventum - Company Sales|Company Sales Revenue EHC|UHS - Company Revenue|DaVita Corp - Company Total Sales|RadNet, Inc. (RDNT) - Company Revenue|Company Total Revenue optioncarehealth.com (OPCH)|SGRY (Surgery Partners) - Revenue and Sales Volume|Premier Inc (PINC) - Company Gross Revenue|Company Revenue National Vision Corp (EYE)|Progyny Corp - Company Sales Volume|Ardent Health Partners, Inc. - Company Sales|Company Total Sales SEM (selectmedical.com)|ASTH: Company Sales|Company Sales Revenue MD (Pediatrix)|USPH: Revenue and Sales Volume|Company Sales The Pennant Group Corp|Company Revenue Organogenesis Holdings|Company Total Revenue nutexhealth.com NUTX|Company Revenue Auna (AUNA)|SBC (SBC Medical Group) - Company Sales Revenue|Company Revenue Jeuveau EOLS|CYH (Community Health Corp) - Company Annual Revenue|SKIN: Company Sales|Company Gross Revenue MediWound Ltd. MDWD|biote Corp (BTMD) - Company Revenue|DCGO: Company Total Sales|Company Sales PIII|Company Total Revenue Gain Therapeutics Inc. GANX|Company Revenue EUDA Health (EUDA)|baselmedical.com - Company Sales Volume|CollPlant Biotechnologies Ltd. - Company Sales|Company Total Sales CUPR (Cuprina Holdings (Cayman) Ltd.)|CCM: Company Sales|ASHS - Company Total Sales|MEDIROM (MRM) - Company Revenue|Avalon GloboCare Corp. - Company Sales Revenue|DHAI (DIH Holding) - Revenue and Sales Volume|Company Total Revenue Carmell Therapeutics Corporation XAGE|Revenue and Sales Volume NIVF|Revenue and Sales Volume atipt.com (ATIP)|CareMax, Inc. - Company Sales|Company Total Sales KDLY (kindlymd.com)|MODV - Company Revenue|Novo Integrated Sciences Inc (NVOS) - Company Sales|SSY: Revenue and Sales Volume|Company Total Revenue IMAC Corp (BACK)